Clinical Trial Update: A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for filgotinib in Korean participants with rheumatoid arthritis. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: ACTIVE_NOT_RECRUITING